Synthesis and Biological Evaluation of Nipecotic Acid Derivatives with Terminally Double-Substituted Allenic Spacers as mGAT4 Inhibitors
Journal of Medicinal Chemistry · 09.10.2025 · 68 (19) · 19984-20010
DOI: 10.1021/acs.jmedchem.5c00520 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 18.09.2025. Verfasst von Maren Jung und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy─Center for Drug Research, Ludwig-Maximilians-Universität München, Butenandtstr. 7-13, D-81377 Munich, Germany. Hauptthemen laut MEDLINE: Nipecotic Acids, Anticonvulsants, Enzyme Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Within a series of nipecotic acid derivatives with a four- and five-carbon atom allenic spacer, respectively, connecting the nitrogen of nipecotic acid with up to two aromatic residues, a highly potent mGAT4 inhibitor has been identified. Its (S)-enantiomer, (S)-1-[4,4-bis(4-chlorophenyl)buta-2,3-dien-1-yl]piperidine-3-carboxylic acid [(S)-8d, DDPM-3960], displays potencies in the higher nanomolar range at mGAT4 (pIC50 = 6.59 ± 0.01) and its human equivalent hGAT-3 (pIC50 = 6.49 ± 0.10). It is thus significantly more potent than the well-known mGAT4 inhibitor (S)-SNAP-5114. Molecular docking rationalizes the enantioselectivity of the inhibitory potency. DDPM-3960 is highly bound to serum proteins (>99%), has good brain penetration and stability. It revealed significant anticonvulsant activity in several mouse models of chemically- and electrically induced seizures. Additionally, anxiolytic-like properties of DDPM-3960 were found. These beneficial biological effects observed in mice were accompanied by sedation but not motor impairments, making DDPM-3960 an interesting lead structure for further development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy─Center for Drug Research, Ludwig-Maximilians-Universität München, Butenandtstr. 7-13, D-81377 Munich, Germany.
- Department of Pharmacodynamics, Chair of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna St., 30-688 Kraków, Poland.
- Department of Pharmacokinetics and Physical Pharmacy, Jagiellonian University Medical College, 9 Medyczna St., 30-688 Kraków, Poland.
- First Department of Surgery, Jagiellonian University Medical College 2, Jakubowskiego St., 30-688 Kraków, Poland.
- Institute for Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-Universität Düsseldorf, Universitätsstr. 1, D-40225 Düsseldorf, Germany.
- Center for Structural Studies, Heinrich-Heine-Universität Düsseldorf, Universitätsstr. 1, D-40225 Düsseldorf, Germany.
ORCID-Profile: Jörg Pabel, Holger Gohlke, Klaus T Wanner
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Jung, M., Sałat, K., Höfner, G., Pabel, J., Wyska, E., Sierżęga, M., Furgała-Wojas, A., Gertzen, C. G. W., Gohlke, H., & Wanner, K. T. (2025). Synthesis and Biological Evaluation of Nipecotic Acid Derivatives with Terminally Double-Substituted Allenic Spacers as mGAT4 Inhibitors. Journal of Medicinal Chemistry, 68(19), 19984-20010. https://doi.org/10.1021/acs.jmedchem.5c00520
Vancouver
Jung M, Sałat K, Höfner G, Pabel J, Wyska E, Sierżęga M, et al. Synthesis and Biological Evaluation of Nipecotic Acid Derivatives with Terminally Double-Substituted Allenic Spacers as mGAT4 Inhibitors. Journal of Medicinal Chemistry. 2025;68(19):19984-20010. doi:10.1021/acs.jmedchem.5c00520
BibTeX
@article{Jung2025,
author = {Jung, Maren and Sałat, Kinga and Höfner, Georg and Pabel, Jörg and Wyska, Elżbieta and Sierżęga, Marek and Furgała-Wojas, Anna and Gertzen, Christoph G W and Gohlke, Holger and Wanner, Klaus T},
title = {Synthesis and Biological Evaluation of Nipecotic Acid Derivatives with Terminally Double-Substituted Allenic Spacers as mGAT4 Inhibitors},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {19},
pages = {19984--20010},
doi = {10.1021/acs.jmedchem.5c00520}
}
EUVIMED